+41 91 682 20 40 info@elixi-int.com
Roche – Tecentriq

Roche – Tecentriq

FDA approves Roche's cancer immunotherapy TECENTRIQ (atezolizumab) for people with a specific type of metastatic lung cancer Roche today announced that the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of people with metastatic non-small cell…

Read More
ELIXI In Expopharm 2016

ELIXI in Expopharm 2016

The expopharm is the largest pharmaceutical trade fair in Europe: Many key decision-makers from all sectors of the industry anywhere else  would here. The current major manufacturers present their latest innovations in the industry, the leading software companies present the…

Read More